We also found that the expression of the onco-immune factors (ENO1, MUC1, COL5A1, IL11) that we identified was significantly correlated with FABP7 expression in patient brain cancers, particularly LGG (Figure 2), suggesting the pathological relevance of the results of our transcriptomic analyses. Here, ENO1 is linked to brain cancer.